The foundational stage of almost every molecular biology and biopharmaceutical workflow—breaking open or separating cells—has evolved into a high-tech multibillion-dollar industry. The global Cell Lysis and Dissociation Market was valued at USD 5.30 billion in 2024 and is on a definitive path to reach USD 10.49 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.90%. https://www.databridgemarketresearch.com/